Affiliation
Academic Urology Unit, Royal Marsden Hospital, London, SM2 5PT, UK.Issue Date
2019
Metadata
Show full item recordCitation
Parker CC, James ND, Brawley CD, Clarke NW, Parmar MKB. Radiotherapy for metastatic prostate cancer-authors' reply. Lancet. 2019 Sep 7;394(10201):830.Journal
LancetDOI
10.1016/S0140-6736(19)31829-XPubMed ID
31498099Additional Links
https://dx.doi.org/10.1016/S0140-6736(19)31829-XType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(19)31829-X
Scopus Count
Collections
Related articles
- Postoperative radiotherapy in prostate cancer - Authors' reply.
- Authors: Parker CC, Sargos P, Sydes MR, Kneebone A, Vale C
- Issue date: 2021 May 1
- Androgen deprivation therapy plus salvage radiotherapy after prostatectomy - Authors' reply.
- Authors: Carrie C, Chabaud S
- Issue date: 2020 Jan
- Salvage radiotherapy for patients with rising PSA - Authors' reply.
- Authors: Carrie C, Dussart S
- Issue date: 2016 Aug
- What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply.
- Authors: Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Fendler WP, Czernin J
- Issue date: 2019 Nov
- Reply from authors re: Martin Spahn, Steven Joniau. Positive surgical margin at radical prostatectomy: futile or surgeon-dependent predictor of prostate cancer death? Eur Urol 2013;64:26-8: adjuvant versus salvage radiotherapy in patients with positive surgical margins at radical prostatectomy: that is the question.
- Authors: Mauermann J, Fradet V, Fradet Y
- Issue date: 2013 Jul